Natus fundamentals

You can employ fundamental analysis to find out if Natus Medical is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found thirty-eight available fundamentals for Natus which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Natus Medical Inc fundamentals including its Cash Flow from Operations, Retained Earnings and the relationship between Cash per Share and Price to Earnings To Growth . Given that Natus Medical has Price to Earning of 61.26 times, we recommend you check Natus last-minute market performance to make sure the company can sustain itself down the road.

Natus Medical Inc is rated below average in cash and equivalents category among related companies. It is rated second in short ratio category among related companies . The ratio of Cash and Equivalents to Short Ratio for Natus Medical Inc is about  3,927,419 

Cash and Equivalents

Return On Equity Return On Asset Profit Margin Operating Margin Current Valuation Shares Outstanding Shares Owned by Insiders Shares Owned by Institutions Number of Shares Shorted Price to Earning Price to Book Price to Sales Revenue Gross Profit EBITDA Net Income Cash and Equivalents Cash per Share Total Debt Debt to Equity Current Ratio Book Value Per Share Cash Flow from Operations Short Ratio One Year High One Year Low Earnings Per Share Price to Earnings To Growth Number of Employees Beta Market Capitalization Total Asset Retained Earnings Working Capital Current Asset Current Liabilities Z Score Probability Of Bankruptcy

Natus competes with ABBOTT, MEDTRONIC, STRYKER, INTUITIVE, and BOSTON. Natus Medical Inc offers healthcare solutions used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, headcooling solutions for the treatment of brain injury in newborns, and incubators to control the newborn’s environment; and software systems for managing and tracking disorders and diseases. Natus Medical Inc offer newborn hearing screening product lines consisting of the ALGO, ABaer, AuDX, and EchoScreen newborn hearing screeners; and hearing screening supply solutions that are used with newborn hearing screening devices. It also offers diagnostic hearing assessment product lines, which include the Navigator Pro system, the Scout sport portable diagnostic device, and the AuDX PRO; and diagnostic hearing supply products. In addition, Natus Medical Inc offer monitoring systems, balance and mobility products, newborn brain injury diagnostic products, thermoregulation products, and jaundice management products. Further, it offers photometers, radiometers, patient warming lamps, neonatal heatshields, pediatric scales, blanket warming cabinets, exam lights, oxygen hoods, restraining boards, and newborn circumstraints; neonatal noise attenuators, phototherapy eye masks, and xray shields for reproductive organs; and newborn screening data management products. Natus Medical Inc serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in San Carlos, California.